Skip to main content
SpringerLink
Log in

Congenital Factor V Deficiency

  • Chapter
  • First Online:
Congenital Bleeding Disorders

Abstract

Coagulation factor (F) V has a central role in the coagulation cascade. Following conversion to its active form (FVa), it functions as an essential cofactor in the prothrombinase complex, which accelerates the conversion of prothrombin to thrombin. In addition, this coagulation factor has anticoagulant activity, which acts as a cofactor for activated protein C (APC) for downregulation of FVIII. Congenital FV deficiency, also termed parahemophilia, is a rare bleeding disorder (RBD) with an estimated prevalence of 1 per million in the general population. This disorder most often presents in regions with a high rate of consanguineous marriages. The most common clinical manifestations of this disorder are mucosal and postsurgical bleeds, although life-threatening bleeding episodes are rare. FV deficiency is suspected through prolonged routine coagulation laboratory tests including prothrombin time (PT) and activate thromboplastin time (aPTT). The diagnosis is confirmed by specific diagnostic tests including FV antigen and activity assays. The only available therapeutic choice for patients with FV deficiency is fresh frozen plasma (FFP): the recommended dose is dependent on the location and severity of bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mann KG, Kalafatis M. Factor V. A combination of Dr Jekyll and Mr Hyde. Blood. 2003;101(1):20–30.

    Article  CAS  PubMed  Google Scholar 

  2. Owren P. Parahaemophilia: haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet. 1947;249(6449):446–8.

    Article  Google Scholar 

  3. Rosing J, Tans G, Govers-Riemslag J, Zwaal R, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem. 1980;255(1):274–83.

    PubMed  CAS  Google Scholar 

  4. Shen L, Dahlbäck B, Factor V. protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994;269(29):18735–8.

    PubMed  CAS  Google Scholar 

  5. Bolton-Maggs P, Perry D, Chalmers E, Parapia L, Wilde J, Williams M, et al. The rare coagulation disorders–review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia. 2004;10(5):593–628.

    Article  CAS  PubMed  Google Scholar 

  6. Duckers C, Simioni P, Rosing J, Castoldi E. Advances in understanding the bleeding diathesis in factor V deficiency. Br J Haematol. 2009;146(1):17–26.

    Article  CAS  PubMed  Google Scholar 

  7. Tabibian S, Kazemi A, Dorgalaleh A. Laboratory diagnosis of congenital factor V deficiency, routine, specific coagulation tests with molecular methods. J Cell Mol Anesth. 2016;1(2):87–90.

    Google Scholar 

  8. Duckers C, Simioni P, Spiezia L, Radu C, Gavasso S, Rosing J, et al. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Blood. 2008;112(9):3615–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Favaloro EJ, Posen J, Ramakrishna R, Soltani S, McRae S, Just S, et al. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation. Blood Coagul Fibrinolysis. 2004;15(8):637–47.

    Article  PubMed  Google Scholar 

  10. Peyvandi F, Garagiola I, Biguzzi E. Advances in treatment of bleeding disorders. J Thromb Haemost. 2016;14(11):2095–106.

    Article  CAS  PubMed  Google Scholar 

  11. Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry. 1992;31(15):3777–85.

    Article  CAS  PubMed  Google Scholar 

  12. William H, Earl W. Blood coagulation factor V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood. 1988;71(71):539–55.

    Google Scholar 

  13. Ortel TL, Takahashi N, Putnam FW. Structural model of human ceruloplasmin based on internal triplication, hydrophilic/hydrophobic character, and secondary structure of domains. Proc Natl Acad Sci USA. 1984;81(15):4761–5.

    Article  CAS  PubMed  Google Scholar 

  14. Baumgartner S, Hofmann K, Bucher P, Chiquet-Ehrismann R. The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction. Protein Sci. 1998;7(7):1626–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nicolaes GA, Dahlbäck B. Factor V and thrombotic disease. Arterioscler Thromb Vasc Biol. 2002;22(4):530–8.

    Article  CAS  PubMed  Google Scholar 

  16. Macedo-Ribeiro S, Bode W, Huber R, Quinn-Allen MA. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature (Lond). 1999;402(6760):434.

    Article  CAS  Google Scholar 

  17. Villoutreix BO, Dahlbäck B. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling. Protein Sci. 1998;7(6):1317–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lechtenberg BC, Murray-Rust TA, Johnson DJ, Adams TE, Krishnaswamy S, Camire RM, et al. Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis. Blood. 2013;122(16):2777–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Asselta R, Tenchini M, Duga S. Inherited defects of coagulation factor V: the hemorrhagic side. J Thromb Haemost. 2006;4(1):26–34.

    Article  CAS  PubMed  Google Scholar 

  20. Camire R, Bos M. The molecular basis of factor V and VIII procofactor activation. J Thromb Haemost. 2009;7(12):1951–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994;269(50):31869–80.

    PubMed  CAS  Google Scholar 

  22. Mann KG, Hockin MF, Begin KJ, Kalafatis M. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain. J Biol Chem. 1997;272(33):20678–83.

    Article  CAS  PubMed  Google Scholar 

  23. Thorelli E, Kaufman RJ, Dahlbäck B. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood. 1999;93(8):2552–8.

    PubMed  CAS  Google Scholar 

  24. Hockin M, Kalafatis M, Cawthern K, Simoni P, Mann K, editors. A novel cellular mechanism for factor Va inactivation. 40th Annual Meeting of the American Society of Hematology Blood; 1998.

    Google Scholar 

  25. Kalafatis M, Mann KG. The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307–348 of factor V plays a critical role in factor Va cofactor function. J Biol Chem. 2001;276(21):18614–23.

    Article  CAS  PubMed  Google Scholar 

  26. Christella M, Thomassen L, Castoldi E, Tans G, Magdeleyns E, Delaunoit C, et al. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool. Haematologica. 2003;88(10):1150–6.

    Google Scholar 

  27. Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem. 2004;279(4):2383–93.

    Article  CAS  PubMed  Google Scholar 

  28. Camire RM, Kalafatis M, Cushman M, Tracy RP, Mann KG, Tracy PB. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. J Biol Chem. 1995;270(35):20794–800.

    Article  CAS  PubMed  Google Scholar 

  29. Lippi G, Favaloro EJ, Montagnana M, Manzato F, Guidi GC, Franchini M. Inherited and acquired factor V deficiency. Blood Coagul Fibrinolysis. 2011;22(3):160–6.

    Article  CAS  PubMed  Google Scholar 

  30. Naderi M, Tabibian S, Alizadeh S, Hosseini S, Zaker F, Bamedi T, et al. Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders. Acta Haematol. 2015;133(2):148–54.

    Article  CAS  PubMed  Google Scholar 

  31. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004;104(5):1243–52.

    Article  CAS  PubMed  Google Scholar 

  32. Lippi G, Pasalic L, Favaloro EJ. Detection of mild inherited disorders of blood coagulation: current options and personal recommendations. Expert Rev Hematol. 2015;8(4):527–42.

    Article  CAS  PubMed  Google Scholar 

  33. Asselta R, Peyvandi F. Factor V deficiency. Semin Thromb Hemost. 2009;35(4):382–9.

    Article  CAS  PubMed  Google Scholar 

  34. Acharya S, Coughlin A, Dimichele DM. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost. 2004;2(2):248–56.

    Article  CAS  PubMed  Google Scholar 

  35. Mansouritorghabeh H, Manavifar L, Mobalegh A, Shirdel A. Haemorrhagic manifestations and prevalence of factor V deficiency in North-Eastern Iran. Haemophilia. 2010;16(2):376–80.

    Article  CAS  PubMed  Google Scholar 

  36. Lak M, Sharifian R, Peyvandi F, Mannucci F. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol. 1998;103:1067–9.

    Article  CAS  PubMed  Google Scholar 

  37. Thalji N, Camire RM. Parahemophilia: new insights into factor V deficiency. Semin Thromb Hemost. 2013;39(6):607–12.

    Article  CAS  PubMed  Google Scholar 

  38. Peyvandi F, Palla R, Menegatti M, Siboni S, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10(4):615–21.

    Article  CAS  PubMed  Google Scholar 

  39. Naderi M, Tabibian S, Shamsizadeh M, Dorgalaleh A. Miscarriage and recurrent miscarriage in patients with congenital factor V deficiency: a report of six cases in Iran. Int J Hematol. 2016;103(6):673–5.

    Article  PubMed  Google Scholar 

  40. Diamandis M, Adam F, Kahr W, Wang P, Chorneyko K, Arsenault A, et al. Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis. J Thromb Haemost. 2006;4(5):1086–94.

    Article  CAS  PubMed  Google Scholar 

  41. Blavignac J, Bunimov N, Rivard GE, Hayward CP. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost. 2011;37(6):713–20.

    Article  PubMed  Google Scholar 

  42. Weiss HJ, Lages B, Zheng S, Hayward CP. Platelet factor V New York: a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. Am J Hematol. 2001;66(2):130–9.

    Article  CAS  PubMed  Google Scholar 

  43. Franchini M, Lippi G. Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis. 2011;31(4):449–57.

    Article  CAS  PubMed  Google Scholar 

  44. Miesbach W, Voigt J, Peetz D, Scharrer I. Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin. Med Klin. 2003;98(6):339–43.

    Article  Google Scholar 

  45. Lucia J, Aguilar C. A case of an asymptomatic idiopathic inhibitor to coagulation factor V. Haemophilia. 2005;11(2):178–80.

    Article  CAS  PubMed  Google Scholar 

  46. Takahashi H, Fuse I, Abe T, Yoshino N, Aizawa Y. Acquired factor V inhibitor complicated by Hashimoto’s thyroditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagul Fibrinolysis. 2003;14(1):87–93.

    Article  PubMed  Google Scholar 

  47. Koyama T, Saito T, Kusano T, Hirosawa S. Factor V inhibitor associated with Sjögren’s syndrome. Br J Haematol. 1995;89(4):893–6.

    Article  CAS  PubMed  Google Scholar 

  48. Streiff MB, Ness PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion. 2002;42(1):18–26.

    Article  PubMed  Google Scholar 

  49. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001;233(1):88–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Nesheim ME, Nichols WL, Cole TL, Houston JG, Schenk RB, Mann KG, et al. Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest. 1986;77(2):405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ajzner E, Balogh I, Haramura G, Boda Z, Kalmar K, Pfliegler G, et al. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. J Thromb Haemost. 2003;1(5):943–9.

    Article  CAS  PubMed  Google Scholar 

  52. Ortel TL, Moore KD, Quinn-Allen MA, Okamura T, Sinclair AJ, Lazarchick J, et al. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood. 1998;91(11):4188–96.

    PubMed  CAS  Google Scholar 

  53. Kalafatis M, Simioni P, Tormene D, Beck DO, Luni S, Girolami A. Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood. 2002;99(11):3985–92.

    Article  CAS  PubMed  Google Scholar 

  54. de Raucourt E, Barbier C, Sinda P, Dib M, Peltier JY, Ternisien C. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. Am J Hematol. 2003;74(3):187–90.

    Article  PubMed  Google Scholar 

  55. Nuzzo F, Beshlawi I, Wali Y, Castoldi E. High incidence of intracranial bleeding in factor V-deficient patients with homozygous F5 splicing mutations. Br J Haematol. 2017;179(1):163–6.

    Article  PubMed  Google Scholar 

  56. Murray JM, Rand MD, Egan J, Murphy S, Kim H, Mann K. Factor V New Brunswick: Ala221-to-Val substitution results in reduced cofactor activity. Blood. 1995;86(5):1820–7.

    PubMed  CAS  Google Scholar 

  57. Guasch J, Lensen R, Bertina R. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is “pseudo homozygous” for activated protein C resistance. Thromb Haemost. 1997;77(2):252–7.

    Article  CAS  PubMed  Google Scholar 

  58. Vos H. An online database of mutations and polymorphisms in and around the coagulation factor V gene. J Thromb Haemost. 2007;5(1):185–8.

    Article  CAS  PubMed  Google Scholar 

  59. Castoldi E, Lunghi B, Mingozzi F, Muleo G, Redaelli R, Mariani G, et al. A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population. Haematologica. 2001;86(6):629–33.

    PubMed  CAS  Google Scholar 

  60. Nuzzo F, Bulato C, Nielsen B, Lee K, Wielders S, Simioni P, et al. Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency. Haemophilia. 2015;21(2):241–8.

    Article  CAS  PubMed  Google Scholar 

  61. Castoldi E, Bulato C, Nuzzo F, Nielsen B, Lee K, Key N, et al. Characterisation of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency. J Thromb Haemost. 2013;11:195.

    Article  Google Scholar 

  62. Bain BJ, Bates I, Laffan MA. Dacie and Lewis practical haematology. Amsterdam: Elsevier; 2016.

    Google Scholar 

  63. Bloom JW, Nesheim ME, Mann KG. A rapid technique for the preparation of factor V deficient plasma. Thromb Res. 1979;15(5-6):595–9.

    Article  CAS  PubMed  Google Scholar 

  64. Tilley D, Levit I, Samis JA. Measurement of factor V activity in human plasma using a microplate coagulation assay. JoVE. 2012;67:3822.

    Google Scholar 

  65. Tilley D, Levit I, Samis JA. Development of a microplate coagulation assay for factor V in human plasma. Thromb J. 2011;9(1):11.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al. Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation. Pathology. 2007;39(5):504–11.

    Article  CAS  PubMed  Google Scholar 

  67. Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al. Identification of factor inhibitors by diagnostic haemostasis laboratories. A large multi-centre evaluation. Thromb Haemost. 2006;96(1):73–8.

    PubMed  CAS  Google Scholar 

  68. Knöbl P, Lechner K. Acquired factor V inhibitors. Baillieres Clin Haematol. 1998;11(2):305–18.

    Article  PubMed  Google Scholar 

  69. Ang AL, Kuperan P, Ng CH, Ng HJ. Acquired factor V inhibitor-A problem-based systematic review. Thromb Haemost. 2009;101(5):852–9.

    Article  CAS  PubMed  Google Scholar 

  70. Salooja N, Martin P, Khair K, Liesner R, Hann I. Severe factor V deficiency and neonatal intracranial haemorrhage: a case report. Haemophilia. 2000;6(1):44–6.

    Article  CAS  PubMed  Google Scholar 

  71. Peyvandi F, Menegatti M. Treatment of rare factor deficiencies in 2016. Hematology Am Soc Hematol Educ Program. 2016;2016(1):663–9.

    PubMed  Google Scholar 

  72. Lawrie AS, Berbenni C, Menegatti M, Nardini I, Mackie I, Machin S, et al. In vitro characterizations of the first therapeutic factor V concentrate. Haemophilia. 2014;20:25–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

    Shadi Tabibian & Akbar Dorgalaleh

  2. Division of Hematology, Department of Pediatrics, Children’s Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA

    Rodney M. Camire

Authors
  1. Shadi Tabibian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akbar Dorgalaleh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rodney M. Camire
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rodney M. Camire .

Editor information

Editors and Affiliations

  1. Iran University of Medical Sciences, Departement of Hematology and Blood TransfusionSchool of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

    Akbar Dorgalaleh

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tabibian, S., Dorgalaleh, A., Camire, R.M. (2018). Congenital Factor V Deficiency. In: Dorgalaleh, A. (eds) Congenital Bleeding Disorders . Springer, Cham. https://doi.org/10.1007/978-3-319-76723-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-76723-9_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-76722-2

  • Online ISBN: 978-3-319-76723-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation